文献速递神经肿瘤

FRK通过磷酸化YAP并诱导Siah1介导其泛素化降解抑制胶质母细胞瘤进展

FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1.
PubMed 文献 · Neuro Oncol · 2022-01-01

研究探讨非受体酪氨酸激酶FRK是否通过调控YAP活性抑制胶质母细胞瘤(GBM)恶性进展。在人GBM细胞和颅内GBM模型中,FRK与YAP表达呈负相关,FRK促进YAP泛素化降解从而在体内外抑制肿瘤。机制上FRK磷酸化YAP的Tyr391/407/444位点,招募E3泛素连接酶Siah1催化YAP泛素化降解。

要点

  • FRK与YAP在胶质瘤组织中表达呈负相关。
  • FRK通过磷酸化YAP Tyr391/407/444招募Siah1促其泛素化降解。
  • FRK-Siah1-YAP信号轴可能成为GBM潜在治疗靶点。

核心结论

  • 研究发现FRK通过磷酸化YAP并诱导Siah1介导的泛素化降解发挥抑瘤作用,FRK-Siah1-YAP信号轴可能成为GBM治疗的潜在靶点。

研究设计与样本

  • 研究使用人GBM细胞和颅内GBM模型评估FRK与YAP对GBM恶性生物学行为的影响,并通过免疫印迹和免疫组化检测GBM组织中核心蛋白表达。
  • 研究采用免疫共沉淀、邻近连接 assay、荧光素酶 assay 和泛素化 assay 确定蛋白-蛋白相互作用及相关分子机制。

主要发现

  • FRK与YAP在胶质瘤组织中表达水平呈负相关。
  • FRK促进YAP泛素化降解,在体外和体内导致肿瘤抑制。
  • FRK与YAP相互作用并磷酸化YAP的Tyr391/407/444位点,招募经典E3泛素连接酶Siah1催化YAP泛素化并最终降解。
  • Siah1是FRK启动的YAP去稳定化所必需的。

临床怎么用

  • 原文结论指出FRK-Siah1-YAP信号轴可能作为GBM治疗的潜在靶点,未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We previously report that yes-associated protein (YAP), the core downstream effector of Hippo pathway, promotes the malignant progression of glioblastoma (GBM). However, although classical regulatory mechanisms of YAP are well explored, how YAP is modulated by the Hippo-independent manner remains poorly understood. Meanwhile, the nonreceptor tyrosine kinase Fyn-related kinase (FRK), which exhibits low expression and possesses tumor suppressor effects in GBM, is reported to be involved in regulation of protein phosphorylation. Here, we examined whether FRK could impede tumor progression by modulating YAP activities. METHODS: Human GBM cells and intracranial GBM model were used to assess the effects of FRK and YAP on the malignant biological behaviors of GBM. Immunoblotting and immunohistochemistry were used to detect the expression of core proteins in GBM tissues. Co-immunoprecipitation, proximity ligation assay, luciferase assay and ubiquitination assay were utilized to determine the protein-protein interactions and related molecular mechanisms. RESULTS: The expression levels of FRK and YAP were inversely correlated with each other in glioma tissues. In addition, FRK promoted the ubiquitination and degradation of YAP, leading to tumor suppression in vitro and in vivo. Mechanistically, FRK interacted with and phosphorylated YAP on Tyr391/407/444, which recruited the classical E3 ubiquitin ligase Siah1 to catalyze ubiquitination and eventually degradation of YAP. Siah1 is required for YAP destabilization initiated by FRK. CONCLUSIONS: We identify a novel mechanism by which FRK orchestrates tumor-suppression effect through phosphorylating YAP and inducing its ubiquitination by Siah1. FRK-Siah1-YAP signaling axis may serve as a potential therapeutic target for GBM treatment.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Wang Y, Wang K, Fu J, et al. FRK inhibits glioblastoma progression via phosphorylating YAP and inducing its ubiquitylation and degradation by Siah1. Neuro Oncol. 2022. PMID: 35723276. doi:10.1093/neuonc/noac156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。